Aethlon Medical

$2.72
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.12 (+4.71%) Today

+$0.05 (+1.87%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AEMD and other stocks, options, and ETFs commission-free!

About AEMD

Aethlon Medical, Inc. Common Stock, also called Aethlon Medical, is a therapeutic technology company, which focuses on addressing global health and biodefense needs. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The firm operates through two segments: Aethlon and ESI. The Aethlon segment involves in therapeutic business activities. The ESI segment consists of diagnostic business activities. The company was founded by James A. Joyce in May 1998 and is headquartered in San Diego, CA. The listed name for AEMD is Aethlon Medical, Inc. Common Stock.

CEO

Charles J. Fisher

Employees

Headquarters

San Diego, California

Founded

1998

Market Cap

32.28M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

614.21K

High Today

$2.77

Low Today

$2.57

Open Price

$2.60

Volume

567.43K

52 Week High

$4.34

52 Week Low

$1.18

Collections

AEMD Earnings

-$1.29

-$0.86

-$0.43

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Q2 FY21

Q3 FY21

Estimated

— per share

Actual

Expected Feb 10, After Hours